S20-207 ComBind: Enhanced Protein-Ligand Structure and Affinity Prediction Platform Researchers at Stanford have developed ComBind, a computational platform that improves prediction of how drug molecules bind to their protein targets by combining structural modeling with readily available binding data from other molecules. Ron Dror Joe Paggi